Bone Morphogenetic Proteins Market Expected to Reach USD 587.069 Million Globally in 2022: Transparency Market Research

According to a new market report published by Transparency Market Research “Bone Morphogenetic Proteins Market (Types : rhBMP-2 and rhbmp-7; Applications: Spinal Fusion, Trauma, Reconstructive and Oral- Maxillofacial) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2014 – 2022”, the global bone morphogenetic proteins market was valued at USD 612.601 million in 2013 and is expected to grow at a CAGR of 2.1% during the forecast period from 2014 to 2022 to reach USD 587.069 million in 2022.

Browse the full Bone Morphogenetic Proteins Market Report: http://www.transparencymarketresearch.com/bone-morphogenetic-protein-market.html

To date, autograft bone graft substitutes harvested from the patient’s own body and allografts harvested from human cadaver or animal are considered ideal for healing injured bone tissues. Although, autologus and allogenic bone grafting is an effective treatment of certain spinal disorders, the bone transplantation procedure could prolong hospital stay, increase blood loss, recovery time, risk of infectious disease transmission, and increased stress at the harvest site. Furthermore, autografts are not suitable for elderly patients and allogenic bone grafts in some cases show low bio-activity level. Thus, bone grafting procedures are witnessing a steady shift from allogenic and autologus bone graft substitutes to growth factors such as bone morphogenetic proteins (BMPs) and cell-based matrices. BMPs have the ability to stimulate new bone formation by initiating the differentiation of stem cells into osteoblasts. The BMP products have eliminated the need for bone harvesting and reduced the healing time. Thus, the market for BMPs is increasing owing to better osteoinduction and fusion rate, which have reduced the hospital stay, consequently reducing the overhead expenses.

The global bone morphogenetic proteins market, based on geography, is segmented into North America, Europe, Asia Pacific, and Rest of the World (RoW). In 2013, North America accounted for the majority share of this market globally in terms of revenue and is anticipated to retain its position during the forecast period. Growth in this market is expected to be driven by aging population and the desire to have an active lifestyle. Similarly, increasing incidences of lower back pain, which is commonly observed in people aged between 40 years and 80 years, is also a key factor that is expected to increase the uptake of BMPs in North America. According to the National Institutes of Health statistics, lower back pain was the most common cause of pain, followed by migraine or headache, and neck pain in the U.S. in 2012. Moreover, 28.4% of the population of the U.S. visits physician clinics for chronic lower back pain. Lower back pain is associated common reason for missed work and job-related disability. Thus, patients with back pain are advised spinal fusion procedures, if non-surgical treatment is ineffective. Therefore, growing incidences of lower back pain that requires spinal surgeries is expected to propel demand for bone morphogenetic proteins in North America. Furthermore, in North America spinal fusion surgeries accounted for the largest share of the market at 76.5% in 2013. In addition, according to the Agency for Healthcare Research and Quality (AHRQ), the number of spinal fusion procedures in the U.S. increased by 72% from 2002 (260,000) to 2011 (460,000). The European region followed the North America bone morphogenetic proteins market globally in 2013.

Press Release for Bone Morphogenetic Proteins Market:

http://www.transparencymarketresearch.com/pressrelease/bone-morphogenetic-protein-market.htm

The most promising growth in this market is expected to emerge from the Asia-Pacific region due to rising geriatric population, which is more prone to orthopedic disorders and requires urgent effective care. In addition, the rapidly evolving medical tourism industry in countries such as India, Thailand, and Singapore, rise in disposable income, and growing awareness about orthopedic treatment are few key reasons that are anticipated to propel growth of the BMP market in this region. The BMP market in RoW is underdeveloped and has not expanded due to high cost, reimbursement challenges, and inadequate training of surgeons. Adverse side effects associated with BMP usage have also restricted the uptake of BMPs in these regions.

The market for bone morphogenetic proteins is emerging and is currently occupied by only two players, Medtronic plc and Olympus Biotech Corporation. Of the two, in 2013 Medtronic held the lion’s share due to wide usage of INFUSE. On the other hand, Olympus Biotech accounted for less than 7% of the global BMP market. This is because OP-1/Opgenra is approved for cases, where autologus bone marrow harvesting is not possible or other treatments have failed.

The global bone morphogenetic proteins market is segmented by type as follows:

o  Global Bone Morphogenetic Proteins Market Revenue, by Types

o     rhBMP-2

o     rhBMP-7

o  Global Bone Morphogenetic Proteins Market Revenue, by Application

o     Spinal Fusion

o     Trauma

o     Reconstructive Surgery

o     Oral-Maxillofacial

o  Global Bone Morphogenetic Proteins Market Revenue, by Geography

o     North America

o   Types

o   Applications

o     Europe

o   Types

o   Applications

o     Asia Pacific

o   Types

o   Applications

o     RoW

o   Types

o   Applications

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Mr. Nachiket Ghumare

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

X-ray Market Expected to Reach USD 11.79 Billion Globally in 2022: Transparency Market Research

According to a new market report published by Transparency Market Research “X-ray Market [Product Type: Stationary & Portable (Mobile & Handheld); Technology: Analog & Digital (Computed Radiography & Direct Digital Radiography); Applications: Cardiovascular, Respiratory, Dental, Mammography & Others]: Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 – 2022”, the global X-ray market was valued at USD 7.89 billion in 2013 and is expected to expand at a CAGR of 4.5% from 2014 to 2022 to reach USD 11.79 billion in 2022.

Browse the full report, Table of Contents and Segmentations: http://www.transparencymarketresearch.com/x-ray-market.html

Geographically, the global market has been segmented into six major regions: North America, Europe, Asia Pacific, Latin America, Africa and Rest of the World (RoW). North America accounted for a majority share of the global X-ray market in 2013, followed by Asia Pacific and Europe. The X-ray market is growing steadily at a CAGR of 4.5% due to high prevalence of cardiovascular diseases, respiratory disorders, and breast cancer. According to the World Health Organization (WHO), an estimated 17.5 million people died due to cardiovascular diseases in 2012, accounting for approximately 31% of the global deaths. Moreover, 235 million people were diagnosed with asthma across the world in 2014. X-ray systems play an important role in the diagnosis of respiratory and cardiovascular diseases. High prevalence of these diseases is leading to increased demand for advanced X-rays systems for early diagnosis and effective treatment.

North America was the largest market for X-ray systems in terms of revenue in 2013. Dominance of North America has been majorly attributed to the high prevalence of cardiovascular and respiratory diseases, financial capability to purchase expensive devices, and high awareness about advanced radiology procedures. North America was followed by Asia Pacific. Higher awareness, improving health care infrastructure, rising prevalence of breast cancer, significant growth in medical tourism, and high acceptance of improved radiological procedures are contributing to the growth of the X-ray market in Asia Pacific and improving market share. The X-ray market in Asia Pacific offers large opportunities and is projected to expand at a high rate in the next few years. According to WHO statistics, India and China account for one third of the global breast cancer burden in 2012. Breast cancer accounted for 233,000 new cases and 44,000 deaths in the U.S., followed by China with 187,000 new cases and 48,000 deaths, and India with 145,000 and 70,000 deaths.

Browse the Full Press Release of X-Ray Market: http://www.transparencymarketresearch.com/pressrelease/x-ray-market.htm

Europe was the third largest market for X-ray systems in 2013 due to high awareness about available radiology products, favorable reimbursement policies, high prevalence of cardiovascular and respiratory diseases, and economic stability to purchase expensive radiology equipment. Additionally, as per the WHO estimates, Europe was the highest smoking region in 2008 globally. High prevalence of smoking and significant exposure to particulate matter in countries in Europe has led to serious respiratory disorders in the region. High prevalence of respiratory diseases in various nations in Europe is leading to increased usage of X-ray devices for diagnosis and monitoring of respiratory diseases in the region. Significant growth in medical tourism from North America and Europe to countries across Asia Pacific would also lead to higher number of radiology procedures, driving demand for X-ray systems in these regions.

Latin America is a major market for X-ray systems due to increasing investments by market players in the region. The X-ray market in Latin America is projected to expand at a high rate during the forecast period from 2014 to 2022 and is expected to present huge growth opportunities. Improving health care scenario, rising prevalence of respiratory and cardiovascular diseases, and increasing investments by market players in this region are the major factors fueling the growth of the X-ray market in Latin America. According to the WHO, the prevalence rate of asthma symptoms in children ranged from 20% to 30% in Brazil, Panama, Costa Rica, Peru, and Uruguay in 2013.

Siemens Healthcare, Philips Healthcare, GE Healthcare, Carestream Health, Inc., FUJIFILM Holdings Corporation, Varian Medical Systems, Inc., Shimadzu Corporation, Agfa-Gevaert N.V., Hitachi Medical Corporation, Canon, Inc., Konica Minolta, Inc., and Toshiba Corporation are the major players operating in the global X-ray market. In terms of revenue, Siemens Healthcare, Philips Healthcare, GE Healthcare, Carestream Health, Inc. and FUJIFILM Holdings Corporation operate in most of the segments of the X-ray market, thereby intensifying competition at the global level.

 

The global X-ray market has been segmented as follows:

Global X-ray Market, by Product Type

• Stationary X-ray
• Portable X-ray
• Mobile X-ray
• Handheld X-ray

Global X-ray Market, by Technology

• Analog X-ray
• Digital X-ray
• Computed Radiography
• Direct Digital Radiography

Global X-ray Detectors Market, by Type

• Photostimulable Storage Phosphor (PSP) Detectors
• Flat Panel Detectors
• Indirect FPDs
• Direct FPDs
• Other X-ray Detectors (CCD, CMOS, X-ray Films, etc.)

Global X-ray Market, by Applications

• Cardiovascular
• Respiratory
• Dental
• Mammography
• Others (Abdominal, Orthopedic, etc.)

Global X-ray Market, by Geography

• North America
• Europe
• Asia Pacific
• Latin America
• Africa 
  

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Mr. Nachiket Ghumare

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Could Xiaomi’s New Fingerprint Scanning Technology be Superior to that Used by Apple and Samsung?

Smartphone manufacturer Xiaomi’s latest offering the Mi 4i may be garnering much buzz in the market, but that hasn’t stopped a large chunk of users from already speculating about the company’s next offering, the Mi 5. According to certain sections of the mobile tech industry, Xiaomi is reportedly toying with a new technology for fingerprint scanning for its new smartphone. That the company certainly has a new trick up its sleeve became evident when it filed for a fingerprint scanning technology patent with Chinese industry authorities. According to the latest reports that have emerged, Xiaomi will likely integrate this fingerprint scanning tech with the touch-sensitive buttons that its smartphones already feature.

If this is indeed the case, the fingerprint scanner could be embedded into the phone’s captive keys as opposed to the conventional method of using physical keys for this purpose. The latter technique is already used by Samsung and Apple.

The patent application that Xiaomi has filed states that the device will carry optical as well as bottom fingerprint sensors, which will be embedded into the cover glass’ terminal equipment. 

Over the past few days, leaks of the designs planned by Xiaomi show that the Mi 5 will ostensibly have a 5.2-inch Quad HD display and will operate on Android 5.0 Lollipop. The phone will also pack a Snapdragon 805 chipset and a front (8MP) and rear camera (16MP). The leaks also suggest that the smartphone could carry storage of 16/64 GB with a 3GB RAM. All these features, accentuated by the new and seemingly exciting fingerprint scanner could create the perfect formula for the success of the Mi 5.

It now remains to be seen how the new smartphone braves the competition, as and when it launches.

Qualcomm Establishes Globalization Centre in China to Help Smartphone Makers with Exports, Hopes to Alleviate Damage Done by Antitrust Investigation

In the backdrop of its antitrust case, U.S.-based chipmaker Qualcomm Inc. is now striving to mend its standing in the Chinese electronics market. To this end, the company has announced the launch of a unit dedicated to assisting Chinese smartphone manufacturers in augmenting their exports. The move comes as a part Qualcomm’s efforts to establish itself as a valuable player in the Chinese electronics industry, especially in light of China cutting down on its reliance on foreign technology houses and chip manufacturers. 

Analysts note that as a company that earns about 50% of all revenues from the Chinese market, Qualcomm is trying its best to maintain—if not strengthen—its footing in the Asian economy. Qualcomm currently ranks as the largest chip manufacturer for smartphones. About two-thirds of the company’s profits can be traced back to its wireless patents licensing business. However, it was this very business model that came under intense scrutiny from Chinese regulators. What followed was an investigation stretching on for 15 months. According to market watchers, this antitrust investigation was a result of complaints from a number of leading Chinese smartphone manufacturers who were ostensibly unhappy over Qualcomm’s technology pricing.

The San-Diego-based company, however, refuted these government findings, which stated that the company violated antimonopoly laws in China. Qualcomm also followed this up with an announcement that it was offering a settlement comprising US$975 million in antitrust fine, as well as a slash in royalty rates on mobile handsets it was selling in China. According to the company, the fine heavily dented the company’s fiscal second-quarter profit, and reported a 46% in the same.

The CEO of Qualcomm, Steve Mollenkopf, said last week that since the company had announced the deal with the Chinese government, it had seen more customers willing to sign up licensing agreements. At the same time, Qualcomm needs to up sales to smartphone makers as well, which is why it is now establishing a ‘globalization office’ in the Chinese city of Shenzhen.

Whether or not this strategy works for Qualcomm will only be evident in the coming months.

New Mobility Robot Launched in China and Hong Kong Markets

Debilitating accidents that affect the very quality of life of an individual can cause much physical and mental agony. For the most part, conventional mobility devices available on the market currently are only effective if the patient exhibits a certain degree of mobility themselves. As an answer to this long-standing concern, manufacturers of mobility devices have now begun to make a palpable switch toward mobility robots equipped with sophisticated features.

A case in point would be the launch of the latest mobility robot, REX, which is the result of a partnership between Deltason Medical and Rex Bionics. The mobility robot was recently introduced to the markets of China and Hong Kong, where the market for mobility robots is gaining wider acceptance.

According to Deltason—a distributor of mobility and medical rehabilitation aids—their current aim is to place the REX robots not just in neuro-rehabilitation clinics, but also in the home-use market. The robot carries much promise for those who suffer from mobility problems. Based on information provided by the World Health Organization, Deltason said that a solution such as this has much potential because in Hong Kong alone, about 2,000 citizens reportedly suffer from debilitating spinal cord injury.

The CEO of Rex, Crispin Simon said that Hong Kong is a critical market not just in terms of sales and revenues, but in the context of world-class research and clinical trials. This is further accentuated by Deltason’s reputation as a leading-edge service provider and innovator. The company said that its long-standing service and commitment to the rehabilitation community give it that extra advantage.

Next on the cards for Deltason is foray into other regions so as to expand its geographical footprint. These expansion plans are slated to be deployed over the next 24 months, the company’s head honcho said. This plan also entails signing deals with distribution partners.

The tie-up will roll off at the upcoming Hong Kong International Medical Devices and Supplies Fair, scheduled between May 18 and 20, 2015.

Petronas Chemicals Group (PCG) Targeting Maximum Plant Capacity Utilization in Malaysia as Strategy to Up Sales Volumes

Petronas Chemicals Group Bhd has said that it is striving to up its plant utilization rate in Malaysia so as to achieve higher sales growth. The integrated producer of chemicals is targeting a capacity utilization rate of about 85%. According to the president and CEO of PCG, Datuk Sazali Hamzah, the company was showing impressive progress to this end. 

Already, the operational capacity of the company has shown an encouraging uptick, with the 2014 plant utilization capacity reaching 80% as compared to 78% a year earlier. In the year ahead, the company is positive that it will be able to achieve a capacity utilization rate of up to 85%.

The head honcho of the company said that their latest plant—Sabah Ammonia Urea (SAMUR)—which is scheduled to be fully operational in 2016, will likely help the capacity utilization rate soar beyond the targeted 85%. He was speaking privately to the news organization Bernama during the 3rd edition of the Hazards Asia Pacific symposium in Kuala Lumpur.

Sazali stated that PCG has been on schedule in completing all of its scheduled turnaround activities. The majority of the company’s plants have reported operational excellence, in terms of capacity utilization and reliability. In view of these positive events, Sazali said that the focus now remains on improving unprecedented plant reliability.

This special emphasis on increased plant utilization capacity can be explained thus: The higher the utilization rate and the reliability of a plant, the lower is the cost of production per metric ton. This aspect not only helps drive sales volumes, but also helps achieve higher revenues.

Sazali also updated reporters that the company’s SAMUR project, located in Sipitang, Sabah as well as its other project - Refinery and Petrochemical Integrated Development (RAPID) which operates in Pengerang, Johor, were showing impressive performance and were on course to achieving the desired level of productivity.

Global Ethylene Market is Anticipated to Reach US$ 234.2 Bn by 2020: Transparency Market Research

Transparency Market Research has released a new market report titled “Ethylene Market for Polyethylene, Ethylene Oxide, Ethylene Benzene, Ethylene Dichloride and Others, and Packaging, Automotive, Construction, Agrochemical, Textile and Other End-users - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020.” According to the report, the global ethylene market was valued at US$ 156.0 Bn in 2013 and is projected to reach US$ 234.2 Bn by 2020, expanding at a CAGR of 6.0% from 2014 to 2020

Browse the full report of Ethylene Market: http://www.transparencymarketresearch.com/ethylene-market.html

Ethylene is produced from petrochemicals by steam cracking. It is particularly used for producing polyethylene, ethylene oxide, ethylene benzene, ethylene dichloride, vinyl acetate, and alfa olefins. These compounds and their derivatives such as ultra-high-molecular-weight polyethylene (UHMWPE), high-density polyethylene (HDPE), low-density polyethylene (LDPE), ethylene glycol, glycol ethers, ethanolamine, and acrylonitrile are used in end-user markets such as packaging, automotive, construction, agrochemicals, textiles, and soaps and detergents. In terms of regions, Asia Pacific was the largest segment of the global ethylene market in 2013, owing to the growth of packaging, automotive and construction industries in Asian countries. In terms of volume, Asia Pacific accounted for more than 30% of the global ethylene market in 2013.

Asia Pacific is projected to be the fastest growing market for ethylene during the forecast period. The demand for ethylene in Asia Pacific would be principally driven by rapid rise in the consumption of ethylene in China, India, Malaysia, Thailand and Vietnam. Multinational conglomerates in the plastics industry are gradually shifting their production base to developing Asian economies to take advantage of skilled and cheap labor and less stringent environmental regulations. This is expected to drive the demand for ethylene in the Asia Pacific region in the next few years. The ethylene market in RoW is also projected to expand significantly in the forecast period, while the ethylene market in North America and Europe is estimated to witness moderate growth due to slow yet steady recovery of these developed regions from the economic slowdown. 

Browse the full Press Release of Ethylene Market: http://www.transparencymarketresearch.com/pressrelease/ethylene-market.htm

Key players operating in the ethylene market include Saudi Basic Industries Corporation (SABIC), The Dow Chemical Company, Exxon Mobil Corporation, Royal Dutch Shell plc, China Petroleum & Chemical Corporation (Sinopec Corporation), Chevron Phillips Chemical Company LLC, Total S.A., LyondellBasell Industries, National Petrochemical Company (NPC), and INEOS Group AG.

The report segments the global ethylene market as follows:

Ethylene Market: Application Analysis

• Polyethylene
• Ethylene oxide
• Ethylene benzene
• Ethylene dichloride
• Others (including vinyl acetate and alpha olefins)

Ethylene Market: End-user Analysis

• Packaging
• Automotive
• Construction
• Agrochemical
• Textile
• Others (including soaps & detergents)

Ethylene Market: Regional Analysis

• North America
• Europe
• Asia Pacific

o   China

o   Japan

o   Rest of Asia Pacific

• Latin America
• RoW (Middle East & Africa)

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. 

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact

Mr. Nachiket Ghumare

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/